Birdwatch Archive

Birdwatch Note Rating

2024-12-27 16:45:07 UTC - NOT_HELPFUL

Rated by Participant: 882D2DE413AFDAF01FCA7B565B3582E528349CDACD49E18054A8B3AFD862E2FD
Participant Details

Original Note:

According to journalists, "SoftBank led an investment of $1.1 billion in Roivant. The investment wasn’t about getting in on Axovant; SoftBank thought intepirdine was unlikely to succeed, the person said. But SoftBank was seeking to invest in [his] wider drug portfolio..." https://www.nytimes.com/2023/06/27/us/politics/vivek-ramaswamy-wealth.html

All Note Details

Original Tweet

All Information

  • noteId - 1872646718988194157
  • participantId -
  • raterParticipantId - 882D2DE413AFDAF01FCA7B565B3582E528349CDACD49E18054A8B3AFD862E2FD
  • createdAtMillis - 1735317907939
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 1
  • notHelpfulSourcesMissingOrUnreliable - 1
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 1
  • notHelpfulArgumentativeOrBiased - 1
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 1
  • notHelpfulIrrelevantSources - 1
  • notHelpfulOpinionSpeculation - 1
  • notHelpfulNoteNotNeeded - 1
  • ratingsId - 1872646718988194157882D2DE413AFDAF01FCA7B565B3582E528349CDACD49E18054A8B3AFD862E2FD